In this work we share new insights into how siRNA off-targets can be identified and assessed.
Eliot Morrison, Principal Scientist, Head of Molecular Design Biology, Silence Therapeutics
Using Untargeted Multi-Omics Methods To Improve siRNA Safety And Specificity
12 August, 2026
Watch time: 19 Minutes
Highlights
Takeaways
PREMIUM CONTENT
Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.
Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.
Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.
